Duchenne Trial Halted

Federal regulators have halted Sarepta Therapeutics' trial of its gene therapy to treat Duchenne muscular dystrophy, Stat News reports. The treatment, it adds, provides a smaller version of the dystrophin gene to patients who lack it.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.